中国现代医生
中國現代醫生
중국현대의생
CHINA MODERN DOCTOR
2015年
11期
85-87,91
,共4页
裴元民%孙学玲%尹华山%崔岩%张在斌
裴元民%孫學玲%尹華山%崔巖%張在斌
배원민%손학령%윤화산%최암%장재빈
甲状腺肿瘤%超声造影%甲状腺微小癌%淋巴结清扫
甲狀腺腫瘤%超聲造影%甲狀腺微小癌%淋巴結清掃
갑상선종류%초성조영%갑상선미소암%림파결청소
Thyroid carcinoma%Ultrasound contrast%Thyroid microcarcinoma%Limph node dissection
目的:探讨超声检查在甲状腺癌筛查中的准确性以及甲状腺微小癌的合理术式。方法对益都中心医院近三年来收治的158例甲状腺恶性肿瘤的临床资料进行回顾性分析。结果超声检查对甲状腺癌准确性达到90%以上,结合超声造影后达到98.3%。手术方式采用个体化原则,其中甲状腺微小癌131例中同侧、峡部腺叶切除的同时进行了中央区淋巴结清扫,其中淋巴结转移率为19.8%(26/131)。结论超声检查加超声造影可明显提高对甲状腺癌的检出率,且准确性高,也可对有无淋巴结转移做出一定判断。对于甲状腺微小癌的患者,行甲状腺腺叶切除的同时应该加做中央区淋巴结清扫。
目的:探討超聲檢查在甲狀腺癌篩查中的準確性以及甲狀腺微小癌的閤理術式。方法對益都中心醫院近三年來收治的158例甲狀腺噁性腫瘤的臨床資料進行迴顧性分析。結果超聲檢查對甲狀腺癌準確性達到90%以上,結閤超聲造影後達到98.3%。手術方式採用箇體化原則,其中甲狀腺微小癌131例中同側、峽部腺葉切除的同時進行瞭中央區淋巴結清掃,其中淋巴結轉移率為19.8%(26/131)。結論超聲檢查加超聲造影可明顯提高對甲狀腺癌的檢齣率,且準確性高,也可對有無淋巴結轉移做齣一定判斷。對于甲狀腺微小癌的患者,行甲狀腺腺葉切除的同時應該加做中央區淋巴結清掃。
목적:탐토초성검사재갑상선암사사중적준학성이급갑상선미소암적합리술식。방법대익도중심의원근삼년래수치적158례갑상선악성종류적림상자료진행회고성분석。결과초성검사대갑상선암준학성체도90%이상,결합초성조영후체도98.3%。수술방식채용개체화원칙,기중갑상선미소암131례중동측、협부선협절제적동시진행료중앙구림파결청소,기중림파결전이솔위19.8%(26/131)。결론초성검사가초성조영가명현제고대갑상선암적검출솔,차준학성고,야가대유무림파결전이주출일정판단。대우갑상선미소암적환자,행갑상선선협절제적동시응해가주중앙구림파결청소。
Objective To explore the accuracy of ultrasound in thyroid cancer screening and the reasonable operation of thyroid carcinoma. Methods Clinical data of 158 cases of thyroid carcinoma in recent three years were analyzed ret-rospectively in Yidu Central Hospital. Results The accuracy of ultrasound examination for thyroid carcinoma was more than 90%,even 98.3% combined with ultrasound contrast. Individual surgical approaches were used in this group. Half gland and isthmic portion and majority opposite side excision plus central lymph node dissection had been performed in 131 cases of patients with thyroid microcarcinoma,and lymph node metastasis rate was 19.8%(26/131). Conclusion Ultrasound and ultrasound contrast can significantly improve the detection rate of thyroid carcinoma and with high ac-curacy. It is also useful to make some judgments lymph node metastasis. Central lymph node dissection should be per-formed combining with gland excision in thyroid microcarcinoma.